value-strategies.blogspot.com
Value Strategies: FDA Comparing Diabetes Drugs?
http://value-strategies.blogspot.com/2010/07/fda-comparing-diabetes-drugs.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Saturday, July 17, 2010. FDA Comparing Diabetes Drugs? One of the task's of the U.S. Food and Drug Administration (FDA) is to approve novel drugs. It has often been mentioned that drugs are not compared to each other head-to-head, as would be desirable for comparative effectiveness. Mostly, drugs are still compared to placebo. Subscribe to: Post Comments (Atom). I'm more interesting on. Value-related Bl...
value-strategies.blogspot.com
Value Strategies: Postcard from Hawaii
http://value-strategies.blogspot.com/2010/08/postcard-from-hawaii.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Sunday, August 29, 2010. Do you know these "postcards from XYZ" in The New Yorker which turn out to be long essays? Is it the fresh air and the open-air architecture (which resembles other Pacific islands, as my wife remarks)? Or is it the healthy life style, lots of surfing etc? Or could it be the diet? There has been much attention. Thank you in Hawaiian). August 29, 2010 at 5:08 PM. I actually just r...
value-strategies.blogspot.com
Value Strategies: BP's Safety/PR and Health Care
http://value-strategies.blogspot.com/2010/06/bps-safetypr-and-health-care.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Thursday, June 24, 2010. BP's Safety/PR and Health Care. It has been getting a little quieter around the oil spill in the Gulf of Mexico while the oil is now washed ashore Northwestern Florida (as predicted in this simulation. Time to think about how this situation compares to health care. If you cannot see the video. What does this have to do with BP's Safety and PR? I think that both in oil spills and...
value-strategies.blogspot.com
Value Strategies: Publication Duty for Pharmaceuticals?
http://value-strategies.blogspot.com/2010/10/publication-duty-for-pharmaceuticals.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Thursday, October 14, 2010. Publication Duty for Pharmaceuticals? Cross-posted at PLoS Blog's "Speaking Medicine. A recent case of publication bias fuels the debate over if results of clinical studies sponsored by pharmaceutical companies must be published in European countries. I have become interested in this issue since researching for an editorial. In Value in Health. Shows that taking reboxetine di...
value-strategies.blogspot.com
Value Strategies: AG to Partners: Your report is flawed (too)
http://value-strategies.blogspot.com/2010/06/ag-to-partners-your-report-is-flawed.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Tuesday, June 29, 2010. AG to Partners: Your report is flawed (too). The Globe reports about. And posts a PDF. Of a letter from Massachusetts' Attorney General Office (AGO) back to Partners Healthcare System (see my earlier post. On their assessment). And they don't give back an inch! Subscribe to: Post Comments (Atom). I'm more interesting on. Enter either your email address:. With 4646 blog posts dati...
value-strategies.blogspot.com
Value Strategies: My relocation - both physically and virtually
http://value-strategies.blogspot.com/2010/11/my-relocation-both-physically-and.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Saturday, November 6, 2010. My relocation - both physically and virtually. I relocated to Russia - and my blog to a new website. Physically, I followed my wife to the wonderful little town of Sochi. In Russia's south. I've been here before in the summer of 2008, but now I am going to spend almost an entire academic year here. Sochi won the bid for the 2014 Winter. If you were on the feedburner feed prev...
value-strategies.blogspot.com
Value Strategies: Comparison and Competition through Transparency
http://value-strategies.blogspot.com/2010/06/comparison-and-competition-through.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Wednesday, June 2, 2010. Comparison and Competition through Transparency. I strongly believe that a higher value for patients (the consumers of health care, so to speak) might in many cases only be achieved with more transparency. There are more and more institutions who become more an more transparent:. In a recent article. Of quality and cost of care of procedures from different providers. On thei...
value-strategies.blogspot.com
Value Strategies: Talk on Costs/Value
http://value-strategies.blogspot.com/2010/08/talk-on-costsvalue.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Thursday, August 12, 2010. Today I was invited today to give a talk at MIT / HST's Laboratory for Computational Physiology. The topic was costs, but I tried to tweak the talk a little towards value. Here are my slides. Click here if you cannot see the slides. Subscribe to: Post Comments (Atom). I'm more interesting on. Enter either your email address:. Or click on on of the buttons below.
value-strategies.blogspot.com
Value Strategies: Personal Profile
http://value-strategies.blogspot.com/p/personal-profile.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. You have arrived at the personal profile of Benjamin P. Geisler, MD, MPH - Thanks so much for visiting! The focus of my current research includes probabilistic Markov modeling, cost-effectiveness and value of information analysis. To get in touch, please feel free to send an email. Benjamin P. Geisler, MD, MPH - May 2010. Manuscripts in preparation: list available upon request. Geisler BP, van Dam R, Ga...
value-strategies.blogspot.com
Value Strategies: BP = #Lean ?
http://value-strategies.blogspot.com/2010/07/bp-lean.html
Quality improvement and outcomes, costs, efficiency and value, transparency, strategy and competition. Friday, July 2, 2010. If BP was a hospital, they would have been shut down by the Joint Commission. Points out, a Wall Street Journal article. Called BP's operations on another oil platform in the Gulf of Mexico "lean". Not surprisingly, their efficiency, value, cost-effectiveness, however you want to call it was high. That's because the extra investment in safety (even after repeated citations, min...
